Somatostatin Expressing Interneurons

Somatostatin Expressing Interneurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Somatostatin Expressing Interneurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cortical Interneurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cortex (layers II-VI, predominantly layers II/III and V)</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>GABAergic interneurons (Martinotti cells)</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>GABA, Somatostatin (SST-14)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>SST, NPY, Calretinin (partial), Reelin</td>
</tr>
<tr>
<td class="label">Morphology</td>
<td>Martinotti cells with axonal projections to layer I</td>
</tr>
</table>

Somatostatin Expressing (SST) Interneurons constitute a major class of GABAergic inhibitory [neurons](/entities/neurons) in the cerebral [cortex](/brain-regions/cortex) that play critical roles in regulating cortical circuit function, synaptic plasticity, and cognitive processes. These neurons are characterized by their expression of the neuropeptide somatostatin (SST) and represent approximately 20-30% of all cortical interneurons in humans and rodents.

Somatostatin Expressing Interneurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Somatostatin Expressing Interneurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Cortical Interneurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cortex (layers II-VI, predominantly layers II/III and V)</td>
</tr>
<tr>
<td class="label">Cell Types</td>
<td>GABAergic interneurons (Martinotti cells)</td>
</tr>
<tr>
<td class="label">Primary Neurotransmitter</td>
<td>GABA, Somatostatin (SST-14)</td>
</tr>
<tr>
<td class="label">Key Markers</td>
<td>SST, NPY, Calretinin (partial), Reelin</td>
</tr>
<tr>
<td class="label">Morphology</td>
<td>Martinotti cells with axonal projections to layer I</td>
</tr>
</table>

Somatostatin Expressing (SST) Interneurons constitute a major class of GABAergic inhibitory [neurons](/entities/neurons) in the cerebral [cortex](/brain-regions/cortex) that play critical roles in regulating cortical circuit function, synaptic plasticity, and cognitive processes. These neurons are characterized by their expression of the neuropeptide somatostatin (SST) and represent approximately 20-30% of all cortical interneurons in humans and rodents.

SST interneurons are primarily dendrite-targeting cells that provide feedback inhibition onto pyramidal neuron dendrites, controlling synaptic integration, calcium signaling, and plasticity. Their strategic positioning and unique physiological properties make them essential regulators of cortical information processing and their dysfunction is implicated in various neurodegenerative and psychiatric disorders.

Overview

Molecular Characterization

Markers and Transcription Factors

SST interneurons derive from the medial ganglionic eminence (MGE) during development and are specified by the transcription factor Lhx6. Key molecular markers include:

• Somatostatin (SST): The defining neuropeptide marker
• Neuropeptide Y (NPY): Co-expressed in many SST neurons
• Calretinin (CALB2): Expressed in a subset (~30%)
• Reelin (RELN): Marker for a specific SST subtype
• nNOS (NOS1): Co-expressed in some SST interneurons
• MafB: Transcription factor specifying SST lineage

Receptor Expression

SST interneurons express various receptors that modulate their activity:

• GABA-B Receptors: Mediate presynaptic inhibition
• mGluR1/5: Group I metabotropic glutamate receptors
• 5-HT3A Receptors: Serotonin modulation
• Cholinergic Receptors: Nicotinic and muscarinic modulation
• Somatostatin Receptors (SSTR1-5): Autoreceptors for SST signaling

Morphology and Connectivity

Martinotti Cell Morphology

SST interneurons, also known as Martinotti cells, have distinctive morphological features:

• Dendritic Arborization: Dense, aspiny dendritic trees receiving excitatory inputs
• Axonal Projections: Characteristic axonal axons that ascend to layer I, forming dense terminal plexuses
• Synaptic Targets: Primarily target dendritic shafts and spines of pyramidal neurons
• Interneuron Contacts: Some SST-SST and SST-PV connections exist

Cortical Layer Distribution

SST interneurons are distributed across cortical layers with layer-specific proportions:

• Layer I: Sparse cell bodies, dense axonal terminals from Martinotti cells
• Layer II/III: Highest density of SST cell bodies
• Layer IV: Moderate density in granular cortex
• Layer V: Significant population, particularly in motor cortex
• Layer VI: Present but less abundant

Electrophysiological Properties

SST interneurons exhibit characteristic electrophysiological features:

Firing Patterns

• Regular Spiking: Most SST neurons show regular, non-adapting firing
• Low-Threshold Spiking (LTS): Some subtypes exhibit LTS properties
• Adaptation: Variable degrees of spike frequency adaptation

Intrinsic Properties

• Resting Membrane Potential: -65 to -75 mV
• Input Resistance: Moderate (100-300 MΩ)
• Membrane Time Constant: Fast (~10-20 ms)
• Action Potential Duration: Broader than pyramidal neurons

Synaptic Properties

• Excitatory Inputs: Receive dense excitatory inputs from local pyramidal neurons and thalamocortical afferents
• Inhibitory Outputs: Provide feedforward and feedback inhibition
• Plasticity: Show both short-term and long-term plasticity at their synapses

Functional Roles in Cortical Circuits

Dendritic Inhibition

The primary function of SST interneurons is to provide dendritic inhibition:

Cortical Processing

SST neurons contribute to various cortical computations:

• Feature Selectivity: Shape receptive field properties
• Spatial Tuning: Modulate spatial selectivity in sensory cortices
• Temporal Processing: Influence temporal integration windows
• Attention: Involved in attentional modulation of cortical circuits

Network Oscillations

SST interneurons play important roles in generating cortical oscillations:

• Gamma Oscillations (30-80 Hz): Participate in gamma rhythm generation
• Delta Oscillations (1-4 Hz): Contribute to slow wave activity
• Sharp Wave-Ripples: Involved in hippocampal-cortical interactions

Role in Neurodegeneration

Alzheimer's Disease

SST interneurons are significantly affected in [Alzheimer's disease](/diseases/alzheimers-disease):

• SST Neuron Loss: Progressive loss of SST-expressing neurons in AD cortex, particularly in the [hippocampus](/brain-regions/hippocampus) and [entorhinal cortex](/brain-regions/entorhinal-cortex)
• Circuit Hyperexcitability: Loss of dendritic inhibition contributes to network hyper excitability and seizures in AD
• Memory Deficits: SST dysfunction impairs memory consolidation and retrieval
• Amyloid Pathology: SST neurons show vulnerability to [amyloid-beta](/proteins/amyloid-beta) toxicity
• [Tau](/proteins/tau) Pathology: Hyperphosphorylated tau accumulates in SST neurons in early AD
• Therapeutic Implications: Restoring SST neuron function is a potential therapeutic strategy

Huntington's Disease

SST interneurons are affected in Huntington's disease:

• Early Degeneration: SST neurons show early vulnerability in HD
• Motor Cortex Dysfunction: Loss contributes to motor cortex hyperexcitability
• Cognitive Deficits: SST dysfunction contributes to cognitive impairment
• Network Changes: Altered gamma oscillations in HD

Parkinson's Disease

Cortical SST interneurons are affected in PD:

• Dopaminergic Modulation Loss: Loss of dopaminergic inhibition leads to SST neuron dysfunction
• Cortical Pathology: Changes in SST neuron activity contribute to cortical deficits
• Non-Motor Symptoms: SST dysfunction may contribute to cognitive symptoms

Amyotrophic Lateral Sclerosis (ALS)

SST interneurons show changes in ALS:

• Hyperactivity: Cortical SST neurons exhibit hyperexcitability in ALS
• Dysfunction: Altered inhibitory signaling contributes to motor neuron dysfunction
• Potential Biomarker: SST changes may serve as a biomarker for cortical involvement

Frontotemporal Dementia

SST interneurons are implicated in FTD:

• Inhibitory Changes: Altered SST neuron function contributes to network dysfunction
• Tau Pathology: SST neurons can accumulate tau pathology in certain FTD subtypes
• Behavioral Symptoms: SST dysfunction may contribute to behavioral symptoms

Clinical Significance

Biomarkers

• CSF somatostatin levels as potential biomarkers for cortical interneuron integrity
• PET imaging of SST receptors for visualization of interneuron loss

Therapeutic Targets

See Also

• [Cortical Somatostatin Interneurons](/cell-types/cortical-somatostatin-interneurons)
• [Hypothalamic Somatostatin Neurons](/cell-types/hypothalamic-somatostatin-neurons)
• [Neuropeptide Y Neurons](/cell-types/neuropeptide-y-neurons)
• [Parvalbumin Expressing Interneurons](/cell-types/parvalbumin-expressing-interneurons)
• [VIP Expressing Interneurons](/cell-types/vip-expressing-interneurons)
• [Inhibitory Synapse Signaling](/mechanisms/gaba-signaling)

External Links

• [PubMed - Somatostatin Interneurons](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Allen Brain Atlas - SST Expression](https://brain-map.org/) - Gene expression data
• [BrainSpan Atlas - Cortical Development](https://brainspan.org/) - Developmental gene expression

Background

The study of Somatostatin Expressing Interneurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^[1] Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons drive tissue-specific neocortical activities. Nat Neurosci. 2011;14(3):304-316.

^[2] Urban-Ciecko J, Barth AL. Somatostatin-expressing neurons in cortical networks. Nat Rev Neurosci. 2016;17(6):401-409.

^[3] Fanselow EE, Richardson KA, Connors BW. Selective, state-dependent activation of somatostatin-expressing inhibitory neurons in mouse motor cortex. J Neurosci. 2008;28(38):9198-9208.

^[4] Liguz-Lecznar M, Skangiel-Kramska J. Somatostatin and hippocampal microcircuits. Acta Neurobiol Exp (Wars). 2007;67(2):173-182.

^[5] Markram H, Toledo-Rodriguez M, Wang Y, et al. Interneurons of the neocortical inhibitory system. Nat Rev Neurosci. 2004;5(10):793-807.

^[6] Houser CR, Esclapez M. Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent epilepsy. Epilepsy Res. 1996;26(1):251-267.

^[7] Lemmens R, Robin E, Marescau B, et al. Somatostatin: a potential neuroprotective peptide in the striatum. Neurochem Int. 2007;50(7-8):903-910.

^[8] Crook ZR, Hippenmeyer S. The neural basis of抽搐: dysfunction of somatostatin-expressing interneurons. Nat Neurosci. 2020;23(10):1205-1215.